Latest News and Press Releases

Melbourne, Australia, April 16, 2025 (GLOBE NEWSWIRE) -- iNGENū CRO, a specialist Contract Research Organization with deep expertise in the complex field of sleep medicine, is pleased to announce...

AXS-12 statistically significantly reduced the frequency of cataplexy attacks compared to placebo (p=0.017, primary endpoint) Statistically significant improvement in cognition compared to placebo...

Burlingame, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, Narcolepsy Market is estimated to value at US$ 2.53 Billion in the year 2024, and is anticipated to reach US$...

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...

Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW...

New York, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The global sleep tech devices market size is slated to expand at ~15% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 50...

WORCESTER, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Wake Up Narcolepsy (WUN), a national leader for research and awareness, premiered its Narcolepsy public service announcement in partnership with Red...

New York, USA, June 14, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global ambulatory polysomnography (PSG) systems market is projected to generate a revenue of...

Data on Auvelity demonstrating improved functioning in major depressive disorder Data on Sunosi demonstrating improved cognitive function in patients with excessive daytime sleepiness associated with...

NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...